AI and machine learning success requires solid foundation in data and analytics

Todd Van Meter, CEO of Accuity, says that when partnering with clients, initial clinical denial rates are nearly cut in half and following an appeals process using an AI-driven platform, the final denial rates end up at 1% to 1.5%.

The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.

The Philadelphia health system has committed to returning 10 million hours back to patient care over the next three years using AI, says Dr. Baligh Yehia, president of Jefferson Health.